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During retroviral replication, the synthesis of minus-strand strong-stop DNA by reverse transcriptase (RT) is primed by a cellular tRNA. The 3Ј-terminal 18 to 20 nucleotides in the tRNA bind to a complementary region at the 5Ј portion of the RNA genome termed the primer binding site (PBS). In human immunodeficiency virus type 1 (HIV-1), the 18-nucleotide sequence comprising the PBS indicates that tRNA 3 Lys is the primer for the RT in this virus (20) . In addition to the tRNA 3 Lys -PBS interaction, it has been postulated, on the basis of chemical and enzymatic probing and computer modeling, that additional interactions occur between regions upstream of the HIV-1 PBS and the D, T⌿C, and anticodon loops of the tRNA 3 Lys (11, 12) . For example, it has been proposed that during the initiation of reverse transcription, a specific interaction occurs between an A-rich loop located upstream of the PBS in the HIV-1 genome and the anticodon of tRNA 3 Lys and that dethiolation of mcm 5 S 2 U at position 34 in the anticodon of tRNA 3 Lys destabilizes this interaction (12) . An interaction between regions upstream of the PBS and the T⌿C loop has also been proposed to exist in non-HIV retrovirus (1, 2) . Furthermore, in vitro studies using platinum cross-linking (5, 6) and nuclease digestion studies (21, 26) have also indicated that HIV-1 RT interacts with the D, anticodon, and T⌿C loops of tRNA 3 Lys . These reports, therefore, suggest that the anticodon loop of tRNA 3 Lys interacts with both the genomic template and RT. In this work, we tested the ability of a mutant tRNA 3 Lys to function as a primer tRNA for HIV-1 RT. The anticodon of this tRNA has been altered from SUU (where S ϭ mcm 5 S 2 U) to the suppressor anticodon CUA. We have previously shown that modifying the tRNA 3 Lys anticodon from SUU to CUA does not affect its ability to be selectively packaged into HIV-1 during viral assembly in vivo (10) , even though it is likely that RT sequences within Pr160 gag-pol are probably responsible for carrying the tRNA into the virus (17) . The insensitivity of select packaging of the tRNA to anticodon sequence is also demonstrated by the fact that the other major cellular tRNA Lys isoacceptor, tRNA 1, 2 Lys , whose anticodon is CUU, is also packaged into the virion (13) . In this work, we show that while tRNA 3
Lys

Su
ϩ functions well as a primer for reverse transcription when heat annealed to genomic RNA, it does not serve as a primer when a primer tRNA 3 Lys -genomic RNA template complex made in vivo is used.
MATERIALS AND METHODS
Plasmid construction. pSVK3 is a simian virus 40-based vector (Pharmacia). pMV104-Lys and pMV104-Lys(Su ϩ ) are plasmids containing, respectively, a human tRNA 3 Lys gene fragment and a human amber suppressor tRNA 3 Lys gene fragment (anticodon TTT changed to CTA). The suppressor tRNA 3 Lys gene was created by site-directed mutagenesis. In addition to the sequence coding for tRNA, both tRNA sequences are flanked by cellular sequences, with 328 bases at the 5Ј end and 379 bases at the 3Ј end. Both plasmids were a gift from Ye Shih Ho, Wayne State University. pSVK3.Lys3 contains a human tRNA 3 Lys gene, and pSVK3.Lys3SU ϩ contains a suppressor tRNA gene. The plasmids were constructed by removing a BamHI-EcoRI fragment from the pMV104 plasmids and cloning this fragment in reverse orientation into the EcoRI and BamHI sites of pSVK3.
pSVK3.Lys3Su ϩ G73A was created by PCR mutagenesis, changing G-73 to A in the vector pSVK3.Lys3SU ϩ . The primers used for PCR amplification were primer 1 (5ЈATACGGCTCGCGTTTGTACTGT3Ј), primer 2 (5ЈCCAGGGTT CAAGTCCCTGTTCGGGCAGCATGTCTTTGCTTTTGGG3Ј), primer 3 (5Ј AACAGGGACTTGAACCCTGGA3Ј), and primer 4 (5ЈACCTCTCAGAGAA GCCCATAGC3Ј). Primer 2 introduced tRNA 3 Lys G-73 changed to A (underlined). In the first PCR amplification, fragments upstream (primer 1 and primer 2) and downstream (primer 3 and primer 4) were PCR amplified in two separate reactions (the mixture contained 500 ng of primers, 10 l of 10ϫ amplification buffer, 10 l of 2 mM four-deoxynucleoside triphosphate [dNTP] mix, 2.5 U of Pfu DNA polymerase [Stratagene] , and H 2 O), using 25 cycles consisting of denaturation at 94ЊC for 1 min, annealing at 55ЊC for 2 min, and elongation at 72ЊC for 2 min. In the second PCR amplication, 50 ng of each amplified fragment was combined with PCR mix (500 ng of primer 1 and primer 4), and PCR was carried out for 25 cycles. The PCR products were extracted with phenol-chloroform and precipated with ethanol. The amplified products were digested by NarI and SpeI, and the 386-base fragment was cloned into the NarI and SpeI sites of pSVK3.Lys3SU Construction of SVC21.BH10, SVC21.BH10Lys3, and SVC21.BH10SU ϩ was performed as previously described (10) .
Production of virus and isolation of viral RNA. The methods of production of HIV-1 virus and isolation of viral RNA were as previously described (10) .
Wild-type and mutant tRNA Lys purification. Wild-type and mutant tRNA 3
Lys
were produced in COS-7 cells transfected with the pSVK3 plasmids described above, using the calcium phosphate transfection method as previously described (10) . Total cellular RNAs were extracted from cells by the guanidinium isothiocyanate procedure. The low-molecular-weight RNA fraction which contains tRNAs was isolated by using an AX500 ion-exchange column (Macherey-Nagel) according to the manufacturer's directions. Specific tRNAs can be purified by hybridizing total tRNA to immobilized DNA probes complementary to the tRNA in question (22) . In this method, developed by H. Tsurui and colleagues, the oligonucleotide to be immobilized is synthesized with an aminohexyl linker at the 5Ј end and is chemically immobilized to tresylate silica. The tresylate silica is made by adding tresyl chloride (Fuluka Chemie A.G., Buchs, Switzerland) to diol silica (Shimadzu Technoresearch Co., Kyoto, Japan). We have used this method to purify the following. For wild-type tRNA 3 
, a 30-base DNA probe which is complementary to tRNA bases G-44 to G-73 (CGCCCGAACAGGGACTTGAACCCTGGACCC) is used; for tRNA 3 Lys Su ϩ and tRNA 3
Su ϩ G73A, a 28-base DNA probe which is complementary to tRNA bases A-21 to C-49 (GGACCCTCAGATTTAGA GTCTGATGCTCT) is used. These DNA probes are immobilized via an amino group on the 5Ј terminus onto tresylate silica (kindly provided by H. Tsurui, Juntendo University School of Medicine, Hongo, Japan). The human placental tRNA 1, 2 Lys used in this study was purified by standard chromatographic methods as previously described (13) . The purity of wild-type and mutant tRNA 3 Lys was tested by dot blot hybridization as previously described (10) . The oligonucleotides used to detect the different tRNAs were 5ЈTGGCGCCCGAACAGGG AC3Ј (tRNA 3 (18) were used to extract HIV-1 RT expressed in Escherichia coli containing plasmids coding for the RT subunits (pRT66 and pRT51), with the following modifications: after addition of lysozyme, the cells were incubated at 37ЊC for 30 min, and 6 M urea was used to solubilize RT in the case of RT present in unextractable protein inclusion. The system used for purifying the heterodimeric form was the Waters 626 liquid chromatography system, and the column was a Resources Q column (Pharmacia LKB Biotechnology Inc.). The program used to perform the separation consisted of 3 min of holding with Tris-HCl buffer (25 mM, pH 8.2) at a flow rate of 1 ml/min followed by a linear increase of the NaCl concentration from 0.0 to 0.2 M in 20 min. The eluate was collected as 1 ml per fraction. The purity of the enzyme was confirmed by loading 10 l of each fraction on a sodium dodecyl sulfate-polyacrylamide gel, and the pooled fractions which contained pRT66 and pRT51 were concentrated with a Centricon-50 concentrator (Amicon, Beverly, Mass.) and stored in 50% glycerol. The activity of the concentrated enzyme was determined by RT assay (8) .
tRNA Lys -directed primer extension. The reactions were carried out in a volume of 20 l containing 50 mM Tris-HCl (pH 7.8), 100 mM KCl, 10 mM MgCl 2 , 10 mM dithiotheitol, 0.2 mM dNTP, different concentrations (Ͻ2 pmol) of wild-type or mutant tRNA 3 Lys , and 2 pmol of HIV RNA (497 bases) which was made from AccI-linearized plasmid pHIV-PBS (3) with the MEGAscript transcription system (Ambion). The synthetic genomic RNA comprises the complete R,U5 region, the PBS, leader, and part of the gag coding region. Annealing of tRNA to genomic RNA was accomplished by heating the reaction mixture at 85ЊC for 2.5 min, cooling it to 50ЊC for 8 min, and stabilizing it at 37ЊC for 10 min. To the reaction mix were sequentially added 50 ng of HIV-1 RT, 10 U of RNasin (Promega), and 15 Ci of [␣-
32 P]dCTP (3,000 Ci/mmol; Dupont), and the mix was then incubated at 37ЊC for 1 h. After incubation, the reaction products were precipitated with an equal volume of 2-propanol, and after resuspension of the precipitate in loading buffer (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol), the samples were electrophoresed on a 6% denaturing polyacrylamide gel.
When total viral RNA was used as the source of primer/template, 10 9 copies of viral genomic RNA were used.
Quantitative determination of genomic RNA in an HIV-1 viral RNA sample. Antisense primer A55 (5ЈCTGCTAGAGATTTTCCACACTGAC3Ј) was used for primer extension to quantitate the genomic RNA (4). This primer binds to DNA positions 612 to 635, just upstream of the PBS. To establish a standard curve, a synthetic 497-nucleotide HIV-1 RNA fragment (3) was reverse transcribed from positions 635 to 473 of the HIV genome plus 11 bases of vector sequence, using SUPERSCRIPT II RNase H-RT (BRL-GIBCO). Viral genomic RNA was extended from position 635 to the end of the 5Ј R region. Quantitation of viral genomic RNA and synthetic genomic RNA was done by phosphor imaging (Bio-Rad). The relative intensities of extended signals were used to determine the concentration of genomic RNA in the viral samples by using the standard curve (r 2 ϭ 0.9959). Primer extension by competing wild-type and mutant tRNA 3
. The reaction conditions for primer extension were modified from those described above. The differences are that 0.5 pmol of synthetic genomic RNA was used instead of 2.0 picomol, and 0.2 mM dGTP and TTP and 0.02 mM ddATP and were used instead of 0.2 mM dNTP, conditions which allow the primer to be extended only six bases, which facilitates better separation between extended wild-type and mutant tRNAs on a single-stranded conformation polymorphism (SSCP) polyacrylamide gel (19) . The reaction was carried out in the presence of 15 Ci of [␣-32 P]dCTP (3,000 Ci/mmol; Dupont). After isopropanol precipitation of the reaction mix, the precipitate was resuspended in loading buffer (described above) and electrophoresed in an SSCP gel (10% polyacrylamide-10% glycerol nondenaturing gel, 87.3 cm by 17.1 cm by 0.4 mm) and run at 4ЊC for 22 h at 35 W, using an SA adjustable sequencing system (BRL-GIBCO).
RESULTS
Purification of wild-type and mutant tRNA 3
Lys to be tested as primers. In this work, we tested the abilities of wild-type and mutant tRNA 3 Lys to prime reverse transcription in vitro. The positions of the mutated bases in tRNA 3 Lys are shown in Fig.  1 . These tRNAs were isolated from COS-7 cells which had been transfected with wild-type or mutant tRNA 3 Lys genes. We have used the hybridization procedure of Tsurui et al. (22) to purify the tRNAs from the small amounts of infected cell total tRNA available. Figure 2 shows the one-dimensional (1D) polyacrylamide gel electrophoresis (PAGE) analysis of purified tRNA Lys samples, as well as the total tRNA before purification. The human placental tRNA 1, 2 Lys was previously purified by more standard chromatographic methods (13) . Each tRNA sample was 3Ј end labeled in vitro with 32 pCp and analyzed by PAGE (11% gel). It can be seen that each tRNA sample resolves into only one major species, and we have found that each sample remains as one major species when resolved by 2D PAGE (data not shown).
To further test the purity of each tRNA, dot blots were performed to test the ability of each tRNA sample to hybridize with DNA probes specific for the different tRNA Lys species. The regions on tRNA 3 Lys complementary to these DNA probes are shown in Fig. 1 . The hybridization probes are shorter than the immobilized ones used for tRNA purification and are complementary either to the 3Ј-terminal 18 nucleotides of the tRNA (in Fig. 3 , probes Lys1,2, Lys3, and G73A) or to the 23 bases which include the anticodon arm (in Fig. 3 However, we will show in Fig. 5 , by electrophoretic analysis, that neither of the mutant tRNAs isolated contains detectable wild-type tRNA 3
Lys .
Abilities of wild-type and mutant tRNA
Lys to prime reverse transcription. We tested the abilities of the wild-type and mutant tRNA 3 Lys isoacceptors to prime reverse transcription of minus-strand strong-stop DNA in vitro, using HIV-1 RT and 2 pmol of synthetic genomic RNA. Figure 4A shows the 1D PAGE of the reaction products, while Fig. 4B shows the quantitation of the synthesis of the 249-bp strong-stop DNA, using phosphor imaging. It is clear from Fig. 4 1, 2 Lys is used at 10-foldhigher concentrations than the tRNA 3 Lys species and is only 3% as efficient at priming reverse transcription as tRNA 3 
Lys
. This reduced ability of tRNA 1, 2 Lys to prime reverse transcription is probably due to more than the imperfect matching of this tRNA with the PBS, since recent work has indicated that even when the PBS is altered to match the terminal 3Ј 18 nucleotides of tRNA 1,2 Lys , the PBS is eventually changed back in vivo to the sequence complementary to tRNA 3 Lys (9, 15) . Ability of mutant tRNA 3 Lys to compete with wild-type tRNA 3 Lys for priming of reverse transcription. The reactions represented in Fig. 4 were done with an excess of genomic RNA over the amount of tRNA 3 Lys species used but may still have been insensitive to differences in the ability of each tRNA 3 Lys to bind to the genomic RNA. Therefore, Fig. 5 shows results of another series of experiments which tested the ability of either of the mutant tRNA 3 Lys species to compete with wild-type tRNA 3 Lys for primer function under conditions of tRNA excess over genomic RNA. We have found that the mutant tRNA 3 Lys species can be distinguished from the wild-type tRNA 3 Lys by using SSCP native gel electrophoresis at 4ЊC, when the reverse transcription extensions are limited in length. The reactions represented in Fig. 5 were carried out in the absence of dATP and the presence of ddATP, which will result in a six-base DNA extension of the primer tRNA by RT (the first six bases incorporated are, sequentially, CTGCTA). It can be seen in the first two lanes of Fig. 5A and B that the extended mutant tRNA 3 Lys has a slower electrophoretic mobility than the extended wildtype tRNA 3
. These results also indicate that the isolated mutant tRNA 3 Lys samples are not contaminated with wild-type tRNA 3 Lys . In Fig. 5A , the ratio of the two transcripts depends on the ratio of the two primer tRNAs used, indicating that tRNA 3
Su
ϩ has an equal ability to compete with wild-type tRNA 3 Lys for priming reverse transcription under conditions of tRNA excess. This is not the case for tRNA 3 Lys Su ϩ G73A, since Fig. 5B shows that regardless of the ratio of mutant to wildtype tRNA 3 Lys , the majority of transcripts are made from wildtype tRNA 3
Lys
. These experiments also demonstrate the inhibition of reverse transcription at higher tRNA 3 Lys concentrations, a phenomenon previously reported (7). While both mutant and wildtype tRNA 3 Lys show this inhibitory property, the wild-type form appears to be a more efficient inhibitor of reverse transcription than either mutant tRNA.
Ability of tRNA 3
Lys Su ؉ packaged in virions to initiate reverse transcription. Instead of using heat-annealed tRNA as the source of the primer for RT, we used total viral RNA extracted from virions as the source of primer/template in an in vitro reaction using HIV-1 RT and conditions which allow only a six-base extension (the reaction mixture lacks dATP and contains ddATP). We have previously shown that when COS-7 cells are transfected with a plasmid containing both HIV-1 proviral DNA and a tRNA 3 Lys gene (wild type or tRNA 3 Lys Su ϩ ), the plasmid-derived tRNA is packaged into the virus (10) . In the experiments shown in Fig. 6 
Su
ϩ G73A, in addition to the mutant anticodon, also has G-73 changed to A. The sequences between the arrows show the regions of tRNA hybridized with the DNA probes used in Fig. 3 to detect the different tRNAs. Thus, the Lys3 and G73A probes are complementary to the tRNA region between arrows 3 and 4, while the Su ϩ probe is complementary to the tRNA region between arrows 1 and 2. The Lys1,2 probe is complementary to the 3Ј-terminal 18 nucleotides of tRNA 1,2 Lys , which differs from the same region in tRNA 3 Lys at five base positions. 
G73A
) were purified by hybridizing cellular tRNA to immobilized DNA probes specific for the tRNA. tRNA 1,2 Lys was purified by more standard chromatographic methods used for tRNA purification. The tRNAs were 3Ј end labeled with 32 pCp and electrophoresed on an 11% denaturing polyacrylamide gel.
placed upon the genome in vivo, since we are unable to anneal exogenous tRNA 3 Lys to synthetic or native genomic RNA under the reaction conditions used here (data not shown). In addition, we have recently identified the in vivo-placed primer tRNA in wild-type virions as tRNA 3 Lys by comparing the T 1 digestion pattern of the tRNA labeled under these conditions with that of purified human placental tRNA 3 Lys heat annealed to synthetic genomic RNA and similarly labeled by reverse transcription (16) . Figure 6 shows the SSCP PAGE pattern of the reverse transcription products. Equal amounts of genomic RNA were used in all reactions. Since the data in Fig. 3 indicate that excess wild-type or mutant tRNA 3 Lys can inhibit in vitro reverse transcription, we performed these experiments with increasing amounts of RT to overcome this inhibition. The use of total viral RNA isolated from wild-type virus (SVC21.BH10) shows no evidence of RT inhibition, while the use of total viral RNA isolated from virus containing either excess wild-type tRNA 3 Lys (SVC21.BH10Lys3) or tRNA 3
does. Increasing concentrations of RT lead to increased synthesis of RT-extended products in both cases. It is clear that in the virus containing both wild-type and mutant tRNA 3 
Lys
, only the wild-type tRNA 3 Lys is used as the primer tRNA. It can also be seen that the amount of product made from RNA isolated from the SVC21.BH10SU ϩ virus is less than that made from RNA isolated from the SVC21.BH10Lys3 virions. The last two lanes in Fig. 6 show the RT extensions from heat-annealed tRNA 3 Lys Su ϩ and tRNA 3 Lys , respectively.
Although tRNA 3 Lys Su ϩ does not act as a primer, it is present in the SV21.BH10SU ϩ virion RNA. This is shown in Fig. 7 , in which total viral RNA from mutant (SVC21.BH10SU ϩ ) or wild-type (SV21.BH10) virions was exposed to heat-annealing conditions. RT extension from both wild-type and mutant tRNA 3 Lys is then seen for SVC21.BH10SU ϩ but not for SV21.BH10. These reactions were performed in the presence of excess synthetic HIV genomic RNA to ensure the opportunity for all primer tRNAs present to hybridize and prime RT. As a result, much less (about 1/10) total viral RNA than used in Fig. 6 is required to obtain detectable reaction products, and inhibition of reverse transcription by excess primer tRNA, using 50 ng of RT per reaction, is not a problem.
DISCUSSION
In this work, we show that a mutant tRNA 3 Lys whose anticodon has been changed from SUU to CUA can still compete well with wild-type tRNA 3 Lys as a primer for initiating reverse transcription when heat annealed to the template in vitro. This competitive assay is more sensitive for detecting differences in priming efficiencies than the ability to prime without competition from wild-type tRNA 3 
Lys
. This is shown when the priming efficiency of tRNA 3 Lys Su ϩ G73A is measured. It has previously been demonstrated that only the terminal six nucleotides at the 5Ј terminus of the HIV PBS are required to be complementary to the 3Ј-terminal six bases of tRNA 3 Lys to initiate priming of minus-strand strong-stop DNA in vivo, and the alteration of a single base within this six-base PBS sequence prevented the initiation of reverse transcription (24) . Our results with tRNA 3 Lys Su ϩ G73A support these findings, for while this tRNA can prime alone with 60% of the efficiency of wildtype tRNA 3 Lys , it competes very poorly with wild-type tRNA 3
Lys for priming reverse transcription. Its ability to function well alone as a primer probably reflects a tolerance for the singlebase mismatch which is eliminated when wild-type tRNA 3 Lys is also present.
Figures 4 and 5 compare the abilities of wild-type and mutant tRNA 3 Lys to prime reverse transcription when heat annealed to the template, while have equal abilities to prime reverse transcription but that only wild-type tRNA 3 Lys can act as a primer when placement occurs in vivo. Because total viral RNA is used as the source of primer tRNA placed onto the template in vivo, the samples used in Fig. 6 have a ratio of tRNA 3 Lys to genomic RNA higher than that used for in vitro experiments represented in Fig. 4 and 5. The tRNA/genomic RNA ratio was kept low in the experiments represented in Fig. 4 so as to maximize the detection of differences in priming ability between wild-type and mutant tRNA 3 Lys when they act alone as primers, and these conditions were also required for the experiments in both Fig. 4 and 5 so as to minimize inhibition of reverse transcription by excess tRNA. However, the inability of tRNA 3 Lys Su ϩ to act as a primer when total viral RNA is used as the source of primer/ template is not due to the different set of conditions represented in Fig. 5 and 6 . First, using total viral RNA containing both mutant and wild-type tRNA 3 
, we are unable to demonstrate priming by in vivo-placed tRNA 3 Lys Su ϩ even when wildtype tRNA 3 Lys priming is substantially increased as a result of relieving tRNA-induced inhibition of reverse transcription by adding excess RT (Fig. 6) . Second, the inability of tRNA 3 Lys Su ϩ to act as a primer when total viral RNA is used is due not to a change in reaction conditions but to the manner of placement on the genome, since as shown in Fig. 7 , as shown in the two right-hand lanes, representing extensions of wild-type and mutant tRNA 3 Lys heat annealed to synthetic genomic RNA.
FIG. 7.
Abilities of heat-annealed viral tRNAs to initiate reverse transcription. The reaction conditions are the same as for Fig. 6 except that the total viral RNA (from SVC21.BH10 and SVC21.BH10SU ϩ ) was first denatured at 85ЊC and then annealed back to an excess of synthetic genomic RNA. Exogenous tRNA 3 Lys and tRNA 3 Lys Su ϩ heat annealed to synthetic genomic RNA were run as markers.
